S. Raja

发表

The Duke myasthenia gravis clinic registry: I. Description and demographics

D. Sanders, L. Hobson‐Webb, J. Massey, 2020, Muscle & nerve.

The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor–induced apoptosis

F. Khuri, B. Lefkove, Shi-Yong Sun, 2008, Molecular Cancer Therapeutics.

The Natural Product Honokiol Preferentially Inhibits c-FLIP and Augments Death Receptor-induced Apoptosis

F. Khuri, B. Lefkove, Shi-Yong Sun, 2022 .

Reliability of the triple‐timed up‐and‐go test

E. Yow, D. Sanders, L. Hobson‐Webb, 2018, Muscle & nerve.

Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies

M. Alonso-Alonso, J. Hickman, J. Howard, 2022, Advanced therapeutics.

Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis

F. Khuri, Shi-Yong Sun, Shuzhen Chen, 2010, Molecular Cancer.

Dissecting the roles of DR 4 , DR 5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis

F. Khuri, Shi-Yong Sun, P. Yue, 2022 .

Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B

E. Walter, M. Cohen-Wolkowiez, V. Juel, 2021, Antimicrobial agents and chemotherapy.

Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis

J. Howard, L. Hobson‐Webb, J. Massey, 2020, Journal of Neuroimmunology.

Evaluation of a Digital Handheld Hydrogen Breath Monitor to Diagnose Lactose Malabsorption: Interventional Crossover Study

Simon C. Mathews, S. Harris, S. Raja, 2021, JMIR formative research.

Validation of the triple timed up‐and‐go test in Lambert‐Eaton myasthenia

D. Richman, K. Aleš, A. Smith, 2019, Muscle & nerve.

Reduced plasmablast frequency is associated with seronegative myasthenia gravis

J. Howard, Z. Siddiqi, Cliburn Chan, 2020, Muscle & nerve.

Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers

V. Fowler, H. Chambers, S. Balevic, 2022, Antimicrobial agents and chemotherapy.

Lambert-Eaton Myasthenic Syndrome and Botulism

S. Raja, 2022, Continuum.

Knowledge and perceptions of the COVID‐19 pandemic among patients with myasthenia gravis

D. Sanders, L. Hobson‐Webb, J. Massey, 2020, Muscle & nerve.

Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN‐105 in Healthy Adult Subjects

F. Boakye-Agyeman, D. Laskowitz, T. Tu, 2017, Journal of clinical pharmacology.

C-0142 TITLE : Prophylactic Administration of CN-105 Confers Neuroprotection Against Acute Brain Injury

F. Boakye-Agyeman, D. Laskowitz, T. Tu, 2017 .

The Duke Myasthenia Gravis Clinic Registry: II. Analysis of outcomes

D. Sanders, L. Hobson‐Webb, J. Massey, 2023, Muscle & nerve.

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy

M. Conaway, J. Russell, A. Smith, 2018, Neurology.

First‐in‐Human Studies of MW01‐6‐189WH, a Brain‐Penetrant, Antineuroinflammatory Small‐Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers

L. Sawaki, Tracy Spears, L. V. Van Eldik, 2020, Clinical pharmacology in drug development.

Comparative effectiveness clinical trials to advance treatment of myasthenia gravis

P. Narayanaswami, D. Sanders, J. Guptill, 2018, Annals of the New York Academy of Sciences.

Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults

V. Fowler, H. Chambers, S. Balevic, 2022, Antimicrobial agents and chemotherapy.

Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis

Jay W. Shin, L. Hobson‐Webb, J. Massey, 2019, Experimental Neurology.

Perioperative Outcomes of Thymectomy in Myasthenia Gravis: A Thoracic Surgery Database Analysis.

H. Al-Khalidi, J. Klapper, M. Hartwig, 2021, The Annals of thoracic surgery.

Pancytopenia – (?) An obstacle in the diagnosis and outcome of pediatric acute lymphoblastic leukemia

F. Suman, S. Raja, J. Scott, 2015, South Asian Journal of Cancer.

Clinical outcome measures following plasma exchange for MG exacerbation

J. Howard, J. Massey, V. Juel, 2019, Annals of clinical and translational neurology.

B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity

L. Hobson‐Webb, K. Weinhold, J. Massey, 2017, Front. Neurol..

Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions

M. Cohen-Wolkowiez, R. Randell, S. Balevic, 2022, Infectious Diseases and Therapy.

Pregnancy in MuSK‐positive myasthenia gravis: A single‐center case series

D. Sanders, L. Hobson‐Webb, J. Massey, 2023, Muscle & nerve.

Experience of Daily Life with Generalized Myasthenia Gravis: A Qualitative Investigation and Assessment of Instrument Content Validity

I. Guillemin, D. Rofail, S. Raja, 2023, Neurology and Therapy.

Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study

P. Narayanaswami, Rishi Desai, V. Juel, 2024, The Lancet Neurology.

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers.

J. Gilbert, P. Zanos, Patrick J. Morris, 2024, Clinical pharmacology and therapeutics.